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Peroxynitrite is an oxidant which could be formed in the vasculature by the reaction of superoxide with nitric oxide. It is capable of modifying 
amino acid residues and of initiating lipid peroxidation. In the present study we have shown that peroxynitrite converts low density lipoprotein 
to a form recognized by the macrophage scavenger receptor and that this process is associated with modification of the protein and lipid, and with 
the oxidation of a-tocopherol to a-tocopherol quinone. 
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1. INTRODUCTION 
The development of macrophage-derived foam cells 
within the artery wall is thought to be a key feature of 
the early atherosclerotic lesion [1,2]. Foam cells origi- 
nate from monocyte-derived macrophages [2] which 
take up modified low-density lipoprotein (LDL) in an 
unregulated manner, via the scavenger eceptor(s) [3-51. 
Native LDL does not cause foam cell formation because 
accumulation of cholesteryl esters is prevented by a 
sterol dependent down-regulation of the native LDL 
receptor [3]. LDL can be modified so that is recognized 
by the macrophage scavenger eceptor by any of the 
following means: acetylation [5], acetoacetylation [6], 
malondialdehyde (MDA) treatment [7], hypochlorite 
treatment [S] and oxidation, either by copper [9] or by 
cells such as endothelial cells [IO, 111, smooth muscle 
cells [12], platelets [13] and monocytes/macrophages 
[14,15]. LDL may also be modified by treatment with 
phospholipase C [16] or lipoxygenase plus phospholi- 
pase A, [17], and by haem proteins [18]. 
There is increasing evidence to indicate that oxidized 
LDL is the modified form of LDL which contributes to 
the formation of foam cells in vivo [4,19,20]. However, 
the physiological processes which contribute to this ox- 
idation are not fully understood at present. A number 
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of mechanisms have been proposed involving the gener- 
ation of ‘seeding lipid peroxides’ within the LDL parti- 
cle by the action of 15-lipoxygenase [ 10,14,2 1,221 or by 
superoxide-dependent oxidation [ 12,23,24]. However, 
more recent studies have provided conflicting evidence 
[25,26]. The ‘seeding peroxide’ hypothesis requires the 
presence of agents that are able to promote the break- 
down of peroxide, once inserted into the lipoprotein 
particle. Possible candidates for this role include transi- 
tion metal ions (e.g. copper and iron), either free or 
bound in the prosthetic group of proteins (e.g. haem 
proteins such as haemoglobin). 
Alternatively, the direct abstraction of a hydrogen 
atom from an unsaturated fatty acid could also lead to 
lipid peroxidation within the LDL particle without the 
requirement for ‘seeding peroxides’ and transition metal 
ions. The initiation of this reaction in vivo would re- 
quire the formation of a highly reactive free radical 
oxidant, such as the hydroxyl radical. Beckman and co- 
workers have recently described a possible route for 
hydroxyl radical formation in vivo, which involves the 
reaction of nitric oxide and superoxide [27]. In stimu- 
lated macrophages, superoxide is generated by NADPH 
oxidase, while nitric oxide is generated by the vascular 
endothelium. Nitric oxide modulates vascular tone and 
may react with superoxide to form the peroxynitrite 
anion [27-301. Decomposition of peroxynitrite gener- 
ates a strong oxidant with reactivity similar to the hy- 
droxyl radical which has been shown to initiate lipid 
peroxidation [31-331. We have shown that treatment of 
LDL with peroxynitrite [32], or with nitric oxide and 
superoxide in combination, can modify LDL [33,34]. In 
this study we demonstrate that peroxynitrite-modified 
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LDL is recognized by the macrophage scavenger ecep- 
tor and leads to accumulation of cholesteryl esters 
within these cells. We also describe the effects of per- 
oxynitrite upon the protein, lipid and antioxidant com- 
ponents of the LDL particle. 
2. MATERIALS AND METHODS 
2.1. Preparations 
Peroxynitrite was prepared as described in [32] and the concentra- 
tion of peroxynitrite was determined spectrophotometrically at 302 
nm (E = 1670 M-’ cd). LDL was prepared from human plasma by 
ultracentrifugation through a potassium bromide density gradient as 
described by Chung et al. [35]. 
2.2. Measurement of cholesterol esterification by THP-I macrophages 
THP-1 cells, a human monocytic cell line, were maintained essen- 
tially as described by Hassall [36]. To differentiate cells into macro- 
phages, THP-1 cells were cultured in 6-well plates, in RPM1 medium 
containing 10% foetal calf serum and 100 ng/ml phorbol myristoyl 
acetate (PMA) for 7 days [37]. The cells were then changed to RPM1 
medium containing 0.2% bovine serum albumin (BSA) together with 
100 @ml PMA. After incubation for 24 h, the cells were changed to 
fresh medium containing 0.2% BSA and the appropriate concentra- 
tion of native or peroxynitrite-modified LDL, and the incorporation 
of radiolabelled oleate into cholesteryl oleate was measured. This 
measurement was performed essentially as described by Goldstein et 
al. [38], except hat 1OpM [9,10(n)-3H]oleate/BSA complex (79 Ci/mol) 
was used. After incubation for 24 h, the cells were washed three times 
with PBS and the lipids were extracted from the cell homogenates by 
the method of Bligh and Dyer [39]. Cholesteryl [‘4C]oleate was added 
as the internal standard (0.45 nCi/ml, 8 nM). The neutral ipids were 
then separated by TLC in petroleum ether (6&80°C b.p.)/diethyl 
ether/glacial acetic acid (90:30: 1, v/v/v). 
2.3. Biochemical measurements 
The concentration of trinitrobenzene sulphonate (TNBS) reactive 
amino groups was measured as described in [40] and thiobarbituric 
acid-reactive substances (TBARS) were measured as described in [33]. 
a-Tocopherol and a-tocopherol quinone were determined after extrac- 
tion into n-heptane and analysis by HPLC [34]. Cholesteryl ester 
oxidation products were measured in samples of LDL (200 &ml) 
incubated in the presence of peroxynitrite (4 mM) or CuSO, (100 PM). 
Diethylenetriamine penta acetic acid (DTPA) was added to all incuba- 
tions at a final concentration of 100 ,uM. After incubation for 24 h at 
37“C, samples of the LDL (0.5 ml) were extracted and dissolved in 150 
~1 of tetrahydrofuranlacetonitrile (80:20, v/v) and the products ana- 
lyzed by HPLC as described by Carroll and Rude1 [41]. The mobile 
phase was monitored at 235 nm and products identified by co-chro- 
matography with oxygenated cholesteryl ester standards, prepared by 
treatment of cholesteryl esters of LDL with soybean 15-lipoxygenase. 
Quantitation of oxidation products was constrained to measurement 
of peak area, as extinction coefficients for these cholesteryl ester oxi- 
dation products are unknown. 
3. RESULTS 
Incubation of LDL with peroxynitrite results in an 
increase in electrophoretic mobility of the lipoprotein 
particle [32]. It is well known that some electronegative 
forms of LDL are ligands for the macrophage scavenger 
receptor and in the following series of experiments we 
determined whether peroxynitrite-modified LDL also 
possessed this property. Three preparations of human 
LDL (1 mg/ml) isolated from different donors were 
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modified with peroxynitrite (5 mM) which resulted in a 
range of relative electrophoretic mobility (REM) values 
(1.849). This type of variability has been observed 
using other methods to modify oxidatively LDL when 
isolated from different donors [9,33]. The different sam- 
ples of LDL were added to THP-1 macrophages in 
increasing amounts and, as shown in Fig. 1, this re- 
sulted in a marked increase in the incorporation of 
[3H]oleate into cholesteryl oleate, indicating that this 
modified lipoprotein was being taken up at a much 
greater rate than native LDL. In addition, cholesterol 
esterification was saturable at high concentrations of 
LDL, and was dramatically reduced by polyinosinic 
acid, which inhibits uptake via the macrophage scaven- 
ger receptor. It is clear that, although the extent of 
modification (as measured by REM) and the extent of 
esterification are dependent upon the preparation of 
LDL, each experiment exhibited saturable uptake that 
was inhibited by polyinosinic acid. 
The dependency of enhanced cholesterol esterifica- 
tion upon increase in REM was investigated further by 
increasing THP-1 macrophages with a single prepara- 
tion of LDL treated with different amounts of peroxyni- 
trite to generate samples with a range of REM values 
(l-3.25). The extent of cholesterol esterification de- 
pended upon the electrophoretic mobility of the lipo- 
protein (Fig. 2). This dependence appeared to be com- 
plex; at REM values below 2.0, a small decrease in 
cholesterol esterification was observed in both of the 
Fig. 1. Uptake of peroxynitrite-modified LDL by the macrophage 
scavenger receptor. THP-1 macrophages were preincubated in serum- 
free medium for 24 h, before the effect of peroxynitrite-modified LDL 
upon cholesterol ester&cation was assessed. Results from three inde- 
pendent experiments (filled symbols), using different preparations of 
peroxynitrite-modified LDL, are shown separately and are the mean 
f S.D. of triplicate wells. The effect of polyinosinic acid (30 &ml) 
upon uptake of lOO~g/ml peroxynitrite-modified LDL (open symbols) 
is shown for each preparation. The REM values for each preparation 
were 4.9 (m), 2.54 (0) and 1.80 (A). Native LDL (100 pg/ml) resulted 
in 0.82 f 0.25 nmol [‘Hloleate incorporation/mg (mean & S.D., n = 3). 
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Fig. 2. Relationship between electrophoretic mobility and uptake of 
peroxynitrite-modified LDL by macrophages. THP-1 macrophages 
were preincubated in serum-free medium for 24 h, before the addition 
of LDL which had been treated with increasing amounts of peroxyni- 
trite to generate samples of LDL with a range of REM values. The 
effect of incubation with each form of peroxynitrite-modified LDL 
(loo&ml) upon the incorporation of [sH]oleate into cholesteryl esters 
by THP-1 macrophages i shown. Results are expressed as nmoles of 
[‘Hloleate incorporated into cholesteryl ester/mg cell protein, and are 
the means f S.D. of triplicate wells from a single experiment. 
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independent experiments performed. At REM values 
above 2.0, dramatic increases in theextent of cholesterol 
esterification were observed. The decrease in uptake 
may be due to the production of a ‘partially modified’ 
form of LDL that is recognized by neither the native 
LDL receptor nor the scavenger eceptor of the macro- 
phage. In addition, although increasing REM is associ- 
ated with increased uptake within a single preparation, 
this relationship does not appear to hold when different 
preparations of LDL are compared. 
The change in mobility which occurs during the cop- 
per-dependent oxidation of LDL appears to involve the 
modification of positively charged amino acid residues 
on the protein by lipid decomposition products [9,40]. 
Consistent with this hypothesis, the extent and rate of 
the copper-dependent modification of LDL is acceler- 
ated by the addition of lipid hydroperoxides [42]. In the 
experiments described here peroxynitrite modification 
of LDL was performed in the presence of DTPA which 
inhibits the transition metal-dependent decomposition 
of lipid hydroperoxides. This suggests that modification 
of the LDL particle can occur in the absence of transi- 
tion metals and, furthermore, increasing the lipid perox- 
ide content of the LDL particle did not enhance the 
extent of oxidative modification by peroxynitrite (re- 
sults not shown). 
Treatment of LDL (1 mg/ml) with peroxynitrite (5 
mM) decreased the concentration of TNBS-reactive 
amino groups by 181 + 24 (mean + S.E.M., n = 6) mod- 
ified lysine residues per molecule of apoB. This repre- 
sents a 59% of lysine residues in apoB, and an efficiency 
of between 11.8 and 15.2 peroxynitrite molecules per 
modified amino group. When lysine (1 mM) was treated 
with peroxynitrite (5 mM), the TNBS-reactive amino 
groups were reduced by only 2.3 f 0.5% (mean 
f S.E.M., n = 6), representing an efficiency of between 
89 and 139 peroxynitrite molecules per modified amino 
group. This suggests that lysine residues within apoB 
are more susceptible to peroxynitrite-dependent modifi- 
cation, consistent with the idea that lipid peroxyl radi- 
cal-dependent decomposition of lipids may play an in- 
termediary role in this process. 
We have previously shown that either treatment with 
peroxynitrite or exposure to superoxide and nitric oxide 
depletes the vitamin E content of LDL [32,34]. This 
effect is also observed during copper-dependent oxida- 
tion of LDL [9]. However, unlike copper, peroxynitrite 
B 
4, 
1OG VH 
Fig. 3. Oxidation of a-tocopherol during the oxidation of LDL by 
peroxynitrite. Panel A shows the depletion of a-tocopherol and its 
conversion to a-tocopheroquinone when LDL (250 &ml) was incu- 
bated with the range of peroxynitrite concentrations hown. Panel B 
shows the ESR spectrum of a sample of LDL (6 mg/ml) treated with 
peroxynitrite (3 mM). The ESR conditions were as follows: modula- 
tion amplitude 2 x 105 G, microwave power 100 mW, scan range 
100 G, scan time 4 min. 
183 
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treatment resulted in the oxidation of a-tocopherol to 
a-tocopherol quinone during LDL modification (Fig. 
3a). The reaction of pure a-tocopherol with peroxyni- 
trite also generated a-tocopherol quinone (result not 
shown). Measurement of the esr spectrum during the 
initial exposure of LDL to peroxynitrite revealed the 
characteristic seven line spectrum of the a-tocopheroxy 
radical (Fig. 3b). This result suggests that free radicals 
are generated uring the reaction of peroxynitrite and 
LDL. 
Peroxynitrite-modified LDL was assayed for TBARS 
and when treated with peroxynitrite (5 mM), LDL (1 
mg/ml) contained 5.9 k 0.2 TBARS nmol/mg LDL pro- 
tein (mean + S.E.M., n = 3). Untreated LDL did not 
contain any observable TBARS and no species with 
maximum absorbance at 532 nm was observed during 
incubation of peroxynitrite and TBA. 
In order to compare the effect of treatment of LDL 
with copper (100 PM) and peroxynitrite (l-4 mM) on 
production of oxidation products within the core of the 
LDL particle (within the cholesteryl ester fraction), we 
analyzed the lipid fractions from two preparations of 
LDL after an overnight incubation at 37°C with the 
above agents (Table I). Treatment with peroxynitrite 
generated oxidation products within the cholesteryl 
ester core of the lipoprotein which seemed to parallel 
changes in REM. Copper oxidized LDL, as expected, 
also contained cholesteryl ester oxidation products. 
4. DISCUSSION 
We have clearly demonstrated that peroxynitrite 
treatment modifies LDL to a form which has increased 
electrophoretic mobility [32] and which is recognized by 
the scavenger eceptors which are present on THP-1 
macrophages (Fig. 1). If generated in vivo, peroxyni- 
trite-modified LDL would therefore represent a poten- 
tially atherogenic lipoprotein which could give rise to 
the formation of macrophage-derived foam cells. 
Table I 
LDL (200 fig/ml) from separate preparations were incubated with 
C&O, (100 ,uM) or peroxynitrite (14 mM) for 24 h at 37°C 
Condition Preparation A Preparation B 
REM Peak area REM Peak area 
No addition 1 .o 6.97 1.0 0 
cuso, 3.66 24.79 4.25 23.99 
(100 .uM) 
Peroxynitrite: 
1mM n.d. n.d. 1.27 11.68 
2mM n.d. n.d. 1.425 12.88 
4mM 4.33 52.29 3.6 37.95 
The cholesteryl ester oxidation products were identified as described 
in section 2. The relative electrophoretic mobility (REM) of each 
preparation following treatment was also measured. n.d. indicates not 
determined. 
184 
The mechanism by which peroxynitrite modifies LDL 
is as yet uncertain. The increase in electrophoretic mo- 
bility and decrease in TNBS-reactive amino groups sug- 
gest that chemical modification of lysine residues has 
occurred. The number of lysine residues which require 
modification before maximal recognition by the macro- 
phage scavenger receptor appears to be dependent upon 
the modifying reagent [40,43]. Modification by succinyl- 
ation or acetylation required > 60% of lysine residues 
to be modified whereas modification by malondialde- 
hyde requires only 16% of lysines to give maximal scav- 
enger receptor recognition in human monocyte macro- 
phages. The modification of critical lysine residues of 
the LDL protein rather than the net negative charge of 
the lipoprotein was thought to determine receptor rec- 
ognition [43]. Peroxinitrite treatment of LDL resulted 
in modification of 59% of lysine residues within the 
LDL particle, but of only 2.3% of free lysine in solution. 
This suggests that modification of apoB by peroxyni- 
trite may be occurring indirectly. The detection of both 
TBARS and cholesteryl ester oxidation products indi- 
cates that peroxynitrite is able to generate other reactive 
species which could react with lysine amino groups and 
lead to LDL modification. The source of the TBARS 
remains uncertain, as it is possible that peroxynitrite 
may generate such compounds from the lipid, protein 
or carbohydrate components of LDL. However, the 
oxidation within the lipid core of the LDL particle sug- 
gests that at least some of the TBARS are lipid-derived. 
Vitamin E is the major lipid-soluble radical-trapping 
antioxidant in plasma [44] and in LDL [9], and its deple- 
tion within the LDL particle is usually assumed to occur 
as a result of lipid peroxidation [9]. The virtually stoi- 
chiometric conversion of a-tocopherol to a-tocopherol 
quinone in LDL may indicate that peroxynitrite is react- 
ing directly with a-tocopherol. It is possible that a- 
tocopherol may be acting as a two-electron reductant, 
generating the quinone from a-tocopherol and nitrate 
from peroxynitrite. However, the detection of the CI- 
tocopheroxy radical by ESR also indicates the involve- 
ment of free radicals in the oxidation of this antioxidant 
although they need not necessarily be lipid-derived. For 
example, nitrogen dioxide has recently been shown to 
oxidize a-tocopherol to ol-tocopherol quinone [45]. 
The in vivo relevance of peroxynitrite modification of 
LDL remains speculative. A protective role for nitric 
oxide in the oxidative modification of LDL by mouse 
macrophages has been proposed [46,47]. Jessup et al. 
[47] examined the effects of modulators of cellular nitric 
oxide synthesis, in the presence or absence of PMA (to 
stimulate superoxide generation). In this study, super- 
oxide generation did not appear to play a role in the 
cell-mediated oxidation of LDL even in the presence of 
enhanced nitric oxide formation. Exposure of LDL to 
SIN- 1, a compound which generates peroxynitrite, did 
result in production of substantial amounts of lipid hy- 
droperoxides, in agreement with our findings, but did 
Volume 330, number 2 FEBS LETTERS September 1993 
not generate a high-uptake form of LDL. However, the 
largest increase in REM observed was 1.39. From our 
study of peroxynitrite treatment of LDL it appears 
likely that an REM of approxiately 2 is required for 
enhanced LDL uptake by THP-1 macrophages. A sim- 
ilar observation has been made for copper-oxidized 
LDL incubated with mouse peritoneal macrophages 
[48]. It is possible that within the arterial wall the gener- 
ation of a low steady-state concentration of peroxyni- 
trite may result from a low, but continuous, flux of both 
nitric oxide and superoxide. This low level of oxidant, 
acting over a prolonged period of time, may constitute 
a significant oxidative stress. Peroxynitrite may also act 
to increase the susceptibility of LDL to oxidation by 
other agents such as transition metal ions and haem 
proteins, possibly by depletion of vitamin E [32]. 
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